[Efficacy and safety of venetoclax and azacitidine in the treatment of refractory and relapsed acute myeloid leukemia].
Zong LH, Wu XX, Zhang J, Li MY, Song BQ, Kong JY, Kong X, Hu XH, Bao XB, Qiu HY, Wu DP.
Zong LH, et al. Among authors: wu xx, wu dp.
Zhonghua Xue Ye Xue Za Zhi. 2021 Oct 14;42(10):861-864. doi: 10.3760/cma.j.issn.0253-2727.2021.10.012.
Zhonghua Xue Ye Xue Za Zhi. 2021.
PMID: 34788928
Free PMC article.
Chinese.
No abstract available.